Table 3.

Impact of different factors on clinical response of CBZ and VPA therapy.

Variables	Exp (B) or (OR)	CI (95%)
Gender	1.18	0.63–2.2
Area	0.67	0.36–1.2
Cousingenous marriages	0.91	0.50–1.6
Family history	0.84	0.45–1.5
Perception	0.69	0.32–1.4
Education	1.84	0.50–6.7
SES	2.22	0.54–9.1
Compliance	0.66	0.32–1.3
Generalized tonic clonic seizure	0.58	0.03–10.0
Generalized tonic seizure	0.98	0.04–20.0
Absence seizure	1.16	0.59–2.3
Generalized atonic seizures	0.81	0.02–6.8
Simple partial seizure	0.44	0.02–11.5
Complex partial seizure	1.29	0.58–6.3
Secondary generalized complex seizure	0.22	0.01–4.9
Myoclonic seizure	2.23	0.05–8.8
Febrile seizure	0.29	0.08–10.1
Status Epilepticus	0.31	0.25–1.8

The reference category is poor controlled seizure, EXP (B) mean expected value of prediction using univariate regression analysis.